Trial Profile
Study of aztreonam (AZT) versus cephalosporin (CEP) therapy for the treatment of gram-negative bacteremia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2018
Price :
$35
*
At a glance
- Drugs Aztreonam (Primary) ; Cephalosporins
- Indications Bacteraemia
- Focus Therapeutic Use
- 09 Nov 2018 New trial record
- 07 Oct 2018 Results presented at the IDWeek 2018